Brucellosis is a zoonotic infectious-allergic disease characterized by intoxication and affection of musculoskeletal, nervous and reproductive systems. This disease is endemic to Kazakhstan.
Sources of infection are bovine animals and small cattle. People are usually infected upon eating infected meat, milk, koumiss and sheep cheese. However causative agents may also enter organism through upper airways together with dust particles from wool, manure and soil.
Acute and subacute forms of brucellosis are treated with antibiotics and quinolinic preparations, vaccine therapy and antibrucellar immunoglobulin. Due to their sensitizing effects their use is restricted. Hormonal therapy and immunocorrection are also applied. Complications connected with hormonal therapy are often observed in patients. As a result of regular use of antibacterial preparations microbes become resistant to them, opportunistic and mycotic flora are activated.
Use of EnergoIod preparation in treatment of brucellosis was studied in laboratory animals and volunteers. That is why its effectiveness in this disease must be noted.
- EnergoIod has immunocorrective effect;
- Due to antibacterial effect it affects pathogenic flora, bacteria do not become resistant to it and normal intestinal flora is not disturbed;
- EnergoIod has anti-inflammatory effect;
- It decreases lability of central nervous system;
- It improves conductivity of cell membranes and peroxidation processes;
- It has evident regenerative effect on joints;
- It has secondary analgesic effect;
EnergoIod preparations will help you treat different forms of brucellosis.
Use of EnergoIod in this disease
Use of EnergoIod in this disease
Weight, kg
For disease
Lung disease
Average disease
Severe disease
Single dose, ml
Daily dose, ml
Single dose, ml
Daily dose, ml
Single dose, ml
Daily dose, ml
40
2
4
4
8
6
12
50-60
3
6
6
12
9
18
70-80
4
8
8
16
12
24
90-100
5
10
10
20
15
30
110-120
6
12
12
24
17
34
Use of a concentrate
Shake before use. It requires dilution with cold or cool drinking water (in an amount of 100-200 ml).
The daily dose calculated for 1 kg body weight, depending on the severity and course of the disease is 0.1-0.3 ml / kg body weight / day, divided into 2 doses.
The drug is taken on an empty stomach in the morning and in the evening before going to bed for 30 days.
If necessary, a second course in 15 days.
The number of courses per year depending on the severity of the pathological process.
Carrying out an accelerated rate with the maximum dose for 15 days.